RxDoctor Payments Data
★ My doctorsLook up a doctor →

Christopher Parker, MD

Internal Medicine · Norman, OKNPI 1518251735

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,373 of the $7,189 with a category attached, or 88.6%. It is spread thinly across 32 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,080 and has fallen 64.4% since, to $740 in 2024. Among internal medicine clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,189in general payments, 2019–2025

Across 380 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • AstraZeneca$1K
  • Boehringer Ingelheim$758
  • Actelion Pharmaceuticals US, Inc.$755
  • Abiomed$740
  • Insmed, Inc.$483
  • plus $2K from 26 others

What the payments were for

  • Travel & lodging$70010%
  • Food & beverage$6,37389%
  • Education$1162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK103$1,281
AstraZeneca(2 entities)74$1,255
Boehringer Ingelheim41$758
Actelion Pharmaceuticals US, Inc.37$755
Abiomed2$740
Insmed, Inc.18$483
Advanced Respiratory, Inc17$275
Sanofi11$209
Philips North America LLC8$149
Circassia Inc.9$133
Novartis7$129
Takeda Pharmaceuticals U.S.A., Inc.4$101
Regeneron Healthcare Solutions, Inc.6$97
Bayer2$85
Mylan Specialty L.p.5$79
Baxter Healthcare3$77
Amgen5$75
Jazz Pharmaceuticals Inc.5$74
Teva Pharmaceuticals USA, Inc.4$58
Genentech USA, Inc.3$55
Vapotherm Inc1$55
ANI Pharmaceuticals, Inc.2$45
Veran Medical Technologies, Inc.2$40
Electromed, Inc.2$31
Optinose US, Inc.2$24
Shire North American Group Inc1$21
Covidien LP1$20
United Therapeutics Corporation1$20
Johnson & Johnson1$17
Xeris Pharmaceuticals, Inc.1$17
Sanofi-aventis U.S. LLC1$15
Nabriva Therapeutics, PLC1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,189 in reported general payments places this provider in the 90th percentile of 840 internal medicine providers in Oklahoma.

See all internal medicine providers in Oklahoma →

Medicare billing

Part B allowed, 2024
$25,025
Medicare patients
101
Services billed
148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Norman

See the full list for Oklahoma →

Where these figures come from

Is this you, or does something look wrong? →